SCHEMBL14224657

SCHEMBL14224657

CNC(=O)c1ccc(CNC(=O)[C@H](CS)NC(C)=O)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
EPHX2 P34913 4/20 0.42
NR1H4 Q96RI1 2/20 0.42
NQO2 P16083 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.40
MAPK1 P28482 1/20 0.40
NLRP1 Q9C000 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KCNH2 Q12809 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14197101 0.90 FNTA (0.48) FNTAFNTBEPHX2NR1H4SMN1; SMN2
SCHEMBL14224488 0.83 FNTA (0.40) FNTAFNTBSMN1; SMN2ALDH1A1CA1
SCHEMBL14197096 0.81 GAA (0.39) FNTAFNTBSMN1; SMN2LMNAALDH1A1
SCHEMBL14224778 0.71 TSHR (0.43) ALDH1A1CA1CA2CA12CA3
SCHEMBL14197187 0.69 TSHR (0.42) SMN1; SMN2ALDH1A1CA1CA2CA12
SCHEMBL7356728 0.68 CA12 (0.72) FNTAFNTBSMN1; SMN2ALDH1A1CA1
SCHEMBL22060054 0.68 EPHX2 (0.63) EPHX2NR1H4SMN1; SMN2LMNAMAPK1
SCHEMBL14224777 0.67 GAA (0.49) SMN1; SMN2ALDH1A1KMT2A
SCHEMBL14197089 0.66 GAA (0.48) SMN1; SMN2LMNAALDH1A1HTTKMT2A
SCHEMBL13299209 0.66 KDM4E (0.63) FNTAFNTBSMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7354919-B2 Isoxazole compositions useful as inhibitors of ERK VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-08 US disclosed